Latest Lead News

Andrew Schwartz, Qualitas’ Group Managing Director and Co-Founder, has sold 15.1 million shares to a major global equities manager, marking his first share sale since the IPO while retaining significant control. The move coincides with strong FY25 results and an accelerating FY26 pipeline.

Advance Metals has established a new Mexican Advisory Board to leverage deep local expertise and fast-track its ambitious silver-gold exploration targets in Mexico. The company aims to more than double its silver-equivalent resources to over 200 million ounces with upcoming drilling campaigns.

Alicanto Minerals reports promising early-stage exploration results from its Greater Falun and Sala projects in Sweden, highlighting high-grade assays and new targets that reinforce the region's mineral potential.

Black Cat Syndicate reports visible antimony mineralisation in initial drill holes at Mt Clement, advancing one of Australia’s largest antimony deposits with assays due in November 2025.

Podium Minerals has achieved a metallurgical breakthrough at its Parks Reef project, delivering an 80% recovery of key metals and a 50-fold concentrate grade upgrade. The company is advancing a A$12 million capital raise to accelerate development amid soaring platinum and palladium prices.

Pioneer Lithium has launched its maiden field exploration program at the North Pine Project in Idaho, targeting critical antimony and tungsten deposits near major US mineral developments.

Euro Manganese is pushing forward an optimization program for its Chvaletice Manganese Project to enhance operational efficiency and reduce costs, aligning with surging global demand for high-purity manganese critical to electric vehicle batteries and energy storage.

Botanix Pharmaceuticals reports a strong start to FY26 with a 50% surge in Sofdra prescriptions and a 65% rise in net revenue, underpinned by a larger sales team and operational efficiencies.

Aura Energy announces the immediate resignation of Managing Director Andrew Grove, with Executive Chair Philip Mitchell stepping in to manage operations during critical funding talks. The company remains focused on advancing its uranium and polymetallic projects in Mauritania and Sweden.

Vectus Biosystems has agreed to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics for US$3 million in shares and warrants, gaining a strategic equity position while refocusing on its cardiovascular and fibrosis pipeline.

PWR Holdings has announced significant board changes following its AGM, with founder Kees Weel stepping down as Managing Director to become Chairman, alongside new appointments to key governance roles.

PWR Holdings announces a pivotal leadership transition alongside the completion of its new global headquarters, reporting a transitional FY25 with mixed financial results but a confident outlook for FY26.